https://retina.news.mail.ru/prev780x440/pic/a4/6e/main42005435_01b4260d1aa7689bffd434de20979b31.jpg

the head of the Russian direct investment Fund (RDIF) Kirill Dmitriev said that the Russian treatment of coronavirus COVID-19 has a number of advantages compared to the us — it will take the form of tablets, not to work hard in the form of injections. In interview to the program “Pozdnyakov” on NTV he called the expected registration of the drug an important global event.

According to him, the drug called “Aviewer” will not be sold in pharmacies, and be directed to the clinic. Selling abroad is not planned until completely closed domestic needs.

“Aviewer” production of FUND and group of companies “Chemrar” has already received the approval of the Ministry of health.

Previously, he announced that “Aviewer” — the first Russian drug with direct antiviral action, preventing the replication of the virus SARS-CoV-2, which has proved effective in clinical trials. The world health organization said that without a vaccine to completely eradicate the pandemic will not succeed. Now the development of a vaccine are engaged in laboratories around the world.